Literature DB >> 8586980

IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease.

M Huberman1, B Sredni, L Stern, E Kott, F Shalit.   

Abstract

The production of interleukin-2 (IL-2) and interleukin-6 (IL-6) by peripheral blood mononuclear cells (MNC) was assessed in patients with Alzheimer's disease (AD) who were subdivided into two groups--mild and moderately-severe--according to the severity of the disease, probable vascular dementia (VaD) patients and elderly control subjects. No differences in IL-2 secretion were found between mild AD patients and controls. However, there was a significant increase in IL-2 production both in the moderately-severe AD group and in the VaD group. IL-6 levels in AD patients of both groups were similar and significantly higher than those of VaD and controls. Our results suggest that increased levels of IL-2-production correlate with severity of the dementia, whereas increased levels of IL-6 production seem to be related to AD and thus may play a role in AD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586980     DOI: 10.1016/0022-510x(95)00016-u

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

Review 1.  T-cells in Alzheimer's disease.

Authors:  Terrence Town; Jun Tan; Richard A Flavell; Mike Mullan
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

2.  Association of cognitive performance with interleukin-6 receptor Asp358Ala polymorphism in healthy adults.

Authors:  Daimei Sasayama; Hiroaki Hori; Toshiya Teraishi; Kotaro Hattori; Miho Ota; Junko Matsuo; Yumiko Kawamoto; Yukiko Kinoshita; Naoji Amano; Hiroshi Kunugi
Journal:  J Neural Transm (Vienna)       Date:  2011-08-31       Impact factor: 3.575

Review 3.  Particulate matter and Alzheimer's disease: an intimate connection.

Authors:  Devin R O'Piela; George R Durisek; Yael-Natalie H Escobar; Amy R Mackos; Loren E Wold
Journal:  Trends Mol Med       Date:  2022-07-12       Impact factor: 15.272

4.  Sex effects of interleukin-6 deficiency on neuroinflammation in aged C57Bl/6 mice.

Authors:  V M Miller; D A Lawrence; G A Coccaro; T K Mondal; K Andrews; A Dreiem; R F Seegal
Journal:  Brain Res       Date:  2010-01-11       Impact factor: 3.252

5.  Performance status in elderly patients with acute myeloid leukemia: exploring gene expression signatures of cytokines and chemokines.

Authors:  Ryan D Nipp; Arati V Rao
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-06-19       Impact factor: 6.053

6.  Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers.

Authors:  Ali El Solh; Lilibeth Pineda; Pam Bouquin; Corey Mankowski
Journal:  BMC Geriatr       Date:  2006-08-09       Impact factor: 3.921

7.  Deficiency of Endothelial Nitric Oxide Synthase (eNOS) Exacerbates Brain Damage and Cognitive Deficit in A Mouse Model of Vascular Dementia.

Authors:  Lulu An; Yi Shen; Michael Chopp; Alex Zacharek; Poornima Venkat; Zhili Chen; Wei Li; Yu Qian; Julie Landschoot-Ward; Jieli Chen
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

8.  Loss of APP in mice increases thigmotaxis and is associated with elevated brain expression of IL-13 and IP-10/CXCL10.

Authors:  Karina Mayagoitia; Andrew J Tolan; Shohali Shammi; Samuel D Shin; Jesus A Menchaca; Johnny D Figueroa; Christopher G Wilson; Denise L Bellinger; Abu Shufian Ishtiaq Ahmed; Salvador Soriano
Journal:  Physiol Behav       Date:  2021-07-19

Review 9.  PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease.

Authors:  Milena Morel; Julien Couturier; Claire Lafay-Chebassier; Marc Paccalin; Guylène Page
Journal:  J Cell Mol Med       Date:  2009-07-07       Impact factor: 5.310

10.  Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias.

Authors:  Aiqing Chen; Arthur E Oakley; Maria Monteiro; Katri Tuomela; Louise M Allan; Elizabeta B Mukaetova-Ladinska; John T O'Brien; Raj N Kalaria
Journal:  Neurobiol Aging       Date:  2015-10-30       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.